SCHEMBL7367910

SCHEMBL7367910

COCCOCCCC(N)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
CA2 P00918 1/20 0.38
TSHR P16473 5/20 0.36
EPHX2 P34913 2/20 0.36
CYP3A4 P08684 3/20 0.34
DDAH1 O94760 1/20 0.34
GAA P10253 1/20 0.33
ABCB11 O95342 1/20 0.33
ADRA2B P18089 1/20 0.33
OPRD1 P41143 1/20 0.33
SCN5A Q14524 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
FAAH O00519 1/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
SOAT1 P35610 1/20 0.32
THRB P10828 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18236026 1.00 ALDH1A1 (0.40) ALDH1A1CA2TSHREPHX2CYP3A4
SCHEMBL20520311 1.00 ALDH1A1 (0.40) ALDH1A1CA2TSHREPHX2CYP3A4
SCHEMBL19127324 1.00 ALDH1A1 (0.40) ALDH1A1CA2TSHREPHX2CYP3A4
SCHEMBL22266503 0.98 ALDH1A1 (0.39) ALDH1A1CA2TSHREPHX2CYP3A4
Hydrochloric Acid SCHEMBL30296638 0.98 ALDH1A1 (0.39) ALDH1A1CA2TSHREPHX2CYP3A4
SCHEMBL21341921 0.93 ALDH1A1 (0.48) ALDH1A1CA2TSHREPHX2CYP3A4
SCHEMBL22266509 0.93 ALDH1A1 (0.48) ALDH1A1CA2TSHREPHX2CYP3A4
SCHEMBL21664615 0.91 ALDH1A1 (0.52) ALDH1A1CA2TSHREPHX2CYP3A4
SCHEMBL21341652 0.91 ALDH1A1 (0.52) ALDH1A1CA2TSHREPHX2CYP3A4
SCHEMBL22266385 0.91 ALDH1A1 (0.45) ALDH1A1CA2TSHREPHX2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116437913-A Pharmaceutical compounds for treating complement-mediated disorders 艾其林医药公司 2023-07-14 CN disclosed
CN-114173772-A Inhibitors of CD40-CD154 binding 托尼克斯医药控股公司 2022-03-11 CN disclosed
EP-0871439-A4 SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS RHONE POULENC RORER PHARMA (US) 1999-07-21 EP disclosed
EP-0871439-A1 SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1998-10-21 EP disclosed
WO-1997024117-A1 SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-10 WO disclosed